Literature DB >> 7517489

Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane.

M Nguyen1, Y Shing, J Folkman.   

Abstract

A novel method for quantitating angiogenesis and its inhibition has been developed for the chick embryo. The method is based on the vertical growth of new capillary blood vessels into a collagen gel through two parallel nylon meshes which align the capillaries for counting. Angiogenesis is induced by basic fibroblast growth factor contained within the gel and slowly released by aluminum sucrose octasulfate (sucralfate) or by tumor cells implanted on the gel. The potency of four different angiogenesis inhibitors was compared at concentrations of 0.6 to 600 nmole. This technique may facilitate the discovery and development of angiogenesis inhibitors for clinical application.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517489     DOI: 10.1006/mvre.1994.1003

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  43 in total

1.  The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin.

Authors:  Jing-Chuan Zhang; Fernando Donate; Xiaoping Qi; Nicholas P Ziats; Jose C Juarez; Andrew P Mazar; Yuan-Ping Pang; Keith R McCrae
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-26       Impact factor: 11.205

Review 2.  Current methods for assaying angiogenesis in vitro and in vivo.

Authors:  Carolyn A Staton; Stephen M Stribbling; Simon Tazzyman; Russell Hughes; Nicola J Brown; Claire E Lewis
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

3.  Improved growth factor directed vascularization into fibrin constructs through inclusion of additional extracellular molecules.

Authors:  J D Smith; M E Melhem; K T Magge; A S Waggoner; P G Campbell
Journal:  Microvasc Res       Date:  2007-01-16       Impact factor: 3.514

4.  Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine.

Authors:  Quansheng Zhou; William B Kiosses; Jin Liu; Paul Schimmel
Journal:  Methods       Date:  2008-02       Impact factor: 3.608

5.  Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems.

Authors:  M Cecilia Subauste; Tatyana A Kupriyanova; Erin M Conn; Veronica C Ardi; James P Quigley; Elena I Deryugina
Journal:  Clin Exp Metastasis       Date:  2009-10-20       Impact factor: 5.150

6.  Pharmacoproteomic analysis of a novel cell-permeable peptide inhibitor of tumor-induced angiogenesis.

Authors:  Ji-Young Bang; Eung-Yoon Kim; Dong-Ku Kang; Soo-Ik Chang; Moon-Hi Han; Kwang-Hyun Baek; In-Cheol Kang
Journal:  Mol Cell Proteomics       Date:  2011-05-10       Impact factor: 5.911

Review 7.  The preclinical evaluation of angiogenesis inhibitors.

Authors:  M S O'Reilly
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

8.  Vascular endothelial growth factor C induces angiogenesis in vivo.

Authors:  Y Cao; P Linden; J Farnebo; R Cao; A Eriksson; V Kumar; J H Qi; L Claesson-Welsh; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  Expression of soluble, biologically active recombinant human tumstatin in Escherichia coli.

Authors:  Yi-Qin Luo; Liang-Hua Wang; Qui Yi; Bing-Hua Jiao
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

10.  Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants.

Authors:  Y Hori; D E Hu; K Yasui; R L Smither; G A Gresham; T P Fan
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.